These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6224689)

  • 1. Effect of norfloxacin on Staphylococcus aureus and Pseudomonas aeruginosa in broth, serum and in combination with human polymorphonuclear leukocytes.
    Daschner F; Bassler M; Bosbach U
    Eur J Clin Microbiol; 1983 Jun; 2(3):274-6. PubMed ID: 6224689
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity of norfloxacin against multi-resistant bacteria.
    Machka K; Vogelsang G
    Eur J Clin Microbiol; 1983 Jun; 2(3):270-1. PubMed ID: 6224686
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of ceftriaxone on Pseudomonas aeruginosa and Staphylococcus aureus in broth, serum, and in combination with human polymorphonuclear leukocytes.
    Bassler M; Blaschke H; Just M; Daschner FD
    Chemotherapy; 1982; 28(5):390-6. PubMed ID: 6291868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of enoxacin compared with norfloxacin and amikacin.
    van der Auwera P; de Moor G; Lacroix G; Mambour A; Rossion N; Schuyteneer F
    Eur J Clin Microbiol; 1985 Feb; 4(1):55-8. PubMed ID: 3157568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of azlocillin and piperacillin in subinhibitory and inhibitory concentrations on Staphylococcus aureus and Pseudomonas aeruginosa in broth, in serum and in the presence of human polymorphonuclear leukocytes.
    Bassler M; Depuis W; Utz E; Just HM; Daschner FD
    Eur J Clin Microbiol; 1983 Oct; 2(5):439-44. PubMed ID: 6416838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro activity of norfloxacin against urinary tract pathogens.
    Haase D; Urias B; Harding G; Ronald A
    Eur J Clin Microbiol; 1983 Jun; 2(3):235-41. PubMed ID: 6224679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norfloxacin (MK-0366, AM-715): in vitro activity and cross-resistance with other organic acids including quality control limits for disk diffusion testing.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1983 Jun; 1(2):165-72. PubMed ID: 6232084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activity of three new quinolone antibiotics against recent clinical isolates.
    Forsgren A
    Scand J Infect Dis; 1985; 17(1):91-4. PubMed ID: 3158070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro emergence of Escherichia coli and Pseudomonas aeruginosa strains resistant to norfloxacin and nalidixic acid.
    Piffaretti JC; Demarta A; Leidi-Bulla L; Peduzzi R
    Eur J Clin Microbiol; 1983 Dec; 2(6):600-1. PubMed ID: 6230227
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro activity of norfloxacin against Chlamydia trachomatis.
    Meier-Ewert H; Weil G; Millott G
    Eur J Clin Microbiol; 1983 Jun; 2(3):271-2. PubMed ID: 6224687
    [No Abstract]   [Full Text] [Related]  

  • 11. Bactericidal effects of norfloxacin towards bacteria in urine.
    Lacey RW; Lord VL; Howson GL
    J Antimicrob Chemother; 1984 May; 13 Suppl B():49-54. PubMed ID: 6234275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the in vitro activity of ceftazidime: in culture, in serum and in combination with granulocytes].
    Daschner FD; Bassler M; Grundau D; Dieterle L; Just HM
    Immun Infekt; 1983 Nov; 11(6):221-8. PubMed ID: 6439624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of norfloxacin in urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
    Shah PM; Ottrad M; Stille W
    Eur J Clin Microbiol; 1983 Jun; 2(3):272-4. PubMed ID: 6224688
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the antibacterial activity of norfloxacin (MK 0366, AM 715), a new organic acid, with that of other orally absorbed chemotherapeutic agents.
    Gadebusch HH; Shungu DL; Weinberg E; Chung SK
    Infection; 1982 Jan; 10(1):41-4. PubMed ID: 6461606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens.
    Lowrence RC; Ramakrishnan A; Sundaramoorthy NS; Shyam A; Mohan V; Subbarao HMV; Ulaganathan V; Raman T; Solomon A; Nagarajan S
    J Appl Microbiol; 2018 Feb; 124(2):408-422. PubMed ID: 29178633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar.
    Tenney JH; Maack RW; Chippendale GR
    Antimicrob Agents Chemother; 1983 Jan; 23(1):188-9. PubMed ID: 6219620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of technical factors in the determination of minimal inhibitory concentration by microdilution].
    Forey F; Coulet M; Brun Y; Fleurette J
    Pathol Biol (Paris); 1985 May; 33(5):341-9. PubMed ID: 3162138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antibacterial activity of norfloxacin compared with eight other antimicrobial agents.
    Body BA; Fromtling RA; Shadomy S; Shadomy HJ
    Eur J Clin Microbiol; 1983 Jun; 2(3):230-4. PubMed ID: 6224678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioassay procedures for norfloxacin.
    Bland J; Edison A; Huber J
    Eur J Clin Microbiol; 1983 Jun; 2(3):249-52. PubMed ID: 6224682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of norfloxacin against Enterobacteriaceae and Pseudomonas aeruginosa.
    García-Rodríguez JA; Gómez-García AC; Rodrigo N
    J Antimicrob Chemother; 1984 Aug; 14(2):192-3. PubMed ID: 6238928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.